Quest Diagnostics to Speak at the Banc of America Securities Health Care Conference
May 18, 2004
Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced that Surya N. Mohapatra, Ph.D., President and Chief Executive Officer, is scheduled to speak at the Banc of America Securities Health Care Conference on Wednesday, May 19, 2004, at The Four Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 2:20 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.veracast.com/webcasts/bas/healthcare-2004/id46106253.cfm and to the public on http://www.questdiagnostics.com/. In addition, the archived webcast will be available starting three hours after the presentation.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable healthcare professionals to make decisions that improve health. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and provides advanced information technology solutions to improve patient care. Additional company information is available at: www.questdiagnostics.com.
The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results and outcomes to be materially different. Certain of these risks and uncertainties may include, but are not limited to, competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors described in the Quest Diagnostics Incorporated 2003 Form 10-K and subsequent filings.
SOURCE: Quest Diagnostics Incorporated
CONTACT: Laure Park (Investors), +1-201-393-5030, or Jennifer Somers
(Media), +1-201-393-5700, both of Quest Diagnostics Incorporated
Web site: http://www.questdiagnostics.com/